Darglitazone is a member of the thiazolidinedione class of drugs and an agonist of peroxisome proliferator-activated receptor-γ (PPAR-γ) an orphan member of the nuclear receptor superfamily of transcription factors. It has a variety of insulin-sensitizing effects such as improving glycemic and lipidemic control and is used in the treatment of metabolic disorders such as type II diabetes.
This page contains content from the copyrighted Wikipedia article "Darglitazone"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
